Experienced in Heart Failure

Takashi Akasaka

Tenri, JP 
Experienced in Heart Failure
Tenri, JP 
OverviewLocationsClinical Research

Overview

Takashi Akasaka practices in Tenri, Japan. Mr. Akasaka is rated as an Experienced expert by MediFind in the treatment of Heart Failure. His top areas of expertise are Coronary Heart Disease, Acute Coronary Syndrome, Angina, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 399 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 8 articles in the study of Heart Failure.

Gender
Male

Locations

Tenri, Japan
Other Locations
Nishinomiya-hama, Japan
Wakayama, Japan
Kimiidera, 6418510, Japan
Okazaki, Japan
Tokyo, 1040033, Japan
Gifu-shi, Japan
Fukuoka, Japan
Kyoto, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
a Multinational, Multicenter, Prospective, Open-label, Active-treatment-controlled Randomized Trial: Preventive PCI or Medical Therapy Alone for Vulnerable Atherosclerotic Coronary Plaque_PREVENT Trial
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device, Drug
Study Drug: Optimal Medical treatment
Study Phase: Phase 4
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR)
Enrollment Status: Completed
Publish Date: April 01, 2021
Intervention Type: Diagnostic test
View 1 Less Clinical Trial

399 Total Publications

Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid Leukemia.
Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid Leukemia.
Journal: European journal of haematology
Published: May 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Akasaka's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 37 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile